The European Medicines Agency Approval of Axitinib (Inlyta)...

The Oncologist 2015 / 02 Vol. 20; Iss. 2

The European Medicines Agency Approval of Axitinib (Inlyta) for the Treatment of Advanced Renal Cell Carcinoma After Failure of Prior Treatment With Sunitinib or a Cytokine: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

Tzogani, K., Skibeli, V., Westgaard, I., Dalhus, M., Thoresen, H., Slot, K. B., Damkier, P., Hofland, K., Borregaard, J., Ersboll, J., Salmonson, T., Pieters, R., Sylvester, R., Mickisch, G., Bergh, J
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
20
Language:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2014-0177
Date:
February, 2015
File:
PDF, 737 KB
english, 2015
Conversion to is in progress
Conversion to is failed